Eisai (ESALF) delivered another quarter with Leqembi growth, which is picking up strongly on a sequential basis. Read why I'm ...
Amid Eisai’s efforts to capitalize on a potential growth surge for its Alzheimer’s disease med Leqembi, the Japanese ...
India Today on MSN35m
Two drugs prove to be effective against Alzheimer's disease in new studyA new study has shown that two drugs - lecanemab and donanemab - could help patients stay independently by approximately 10–13 months in the early stage of Alzheimer's disease.
The "Seizures Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The Seizures treatment pipeline analysis provides an overview of recent advancements ...
Catalyst stock gains on strong fourth-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales.
The breast cancer market has experienced robust growth, fueled by increased awareness and early detection efforts. Advances in diagnostic and treatme ...
NEC Corporation (NEC; TSE: 6701) has developed vRAN that supports the interfaces and components newly specified by the O-RAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback